 |
 |
FDA May Pull midodrine hydrochloride Drug By Peggy Peck, Executive Editor, MedPage Today Published: August 16, 2010 WASHINGTON -- The FDA said today that it plans to withdraw marketing approval of the orthostatic hypotension drug midodrine hydrochloride because makers of the compound failed to provide postmarketing evidence of efficacy. .... Makers of generic versions of the drug (Apotex, Impax Laboratories, Mylan Pharmaceuticals, Sandoz, and Upsher-Smith Laboratories) will have "30 days to submit written comments" on today's notice. End of partial quote. Full Article is at: http://www.medpagetoday.com/ProductAlert/Prescriptions/21699 FDA drug label information for midodrine hydrochloride: http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=2585 This drug is the alternative to supp-hose. It is for those patients who experience light headedness upon standing. John Cottingham ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn